4//SEC Filing
Desai Meera J. 4
Accession 0001839882-23-013975
CIK 0000887247other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 6:15 PM ET
Size
5.4 KB
Accession
0001839882-23-013975
Insider Transaction Report
Form 4
Desai Meera J.
Director
Transactions
- Award
Common Stock
2023-05-25+3,138→ 3,138 total
Footnotes (2)
- [F1]On May 22, 2023, Adamis Pharmaceuticals Corporation ("Adamis") effected a 1 for 70 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
- [F2]Received in exchange for common stock of DMK Pharmaceuticals Corporation, a privately held corporation ("DMK"), in connection with the merger of DMK into a subsidiary of Adamis (the "Merger"). On the effective date of the Merger, the closing price of Adamis common stock was $2.50 per share.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeother
Related Parties
1- filerCIK 0001886559
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 6:15 PM ET
- Size
- 5.4 KB